-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Bright Minds Biosciences, Maintains $85 Price Target

Benzinga·09/15/2025 11:10:31
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintains $85 price target.